VADS
HPV.DCVax
Multicentric randomized phase I/IIa trial of the safety and immunogenicity of a;therapeutic anti-HPV DC targeting vaccine in patients with Human papillomavirus;(HPV)-positive oropharyngeal cancer.
Paris
CHRISTOPHE LE TOURNEAU